超过5%股东持股披露
PolyPid(PYPD)04-06 04:15
$PolyPid(PYPD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-030807 Act: 34 Size: 73 KB 网页链接
简介：PolyPid Ltd.是根据以色列法律注册成立，并于2008年2月28日开始运作。该公司是一家3期临床阶段的生物制药公司，专注于利用专有的PLEX技术开发靶向、局部给药和缓释疗法。该公司的候选产品旨在通过将PLEX技术与已获FDA批准的药物或创新候选药物配对，以达到新的治疗效果，从而解决具有高度未满足医疗需求的疾病。
| 今开：4.25 | 昨收：4.2 |
| 最高：4.4 | 最低：4.125 |
| 涨停价： | 跌停价： |
| 总市值：20628184 |
PolyPid(PYPD)04-06 04:15
$PolyPid(PYPD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-030807 Act: 34 Size: 73 KB 网页链接
PolyPid(PYPD)05-29 04:15
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-047069 Act: 34 Size: 166 KB 网页链接
PolyPid(PYPD)06-18 20:15
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-053533 Act: 34 Size: 34 KB 网页链接
PolyPid(PYPD)04-18 04:15
$PolyPid(PYPD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-033795 Act: 34 Size: 46 KB 网页链接
PolyPid(PYPD)05-08 19:15
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040629 Act: 34 Size: 98 KB 网页链接
PolyPid(PYPD)04-30 20:25
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-037474 Act: 34 Size: 29 KB 网页链接
PolyPid(PYPD)05-18 04:05
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-044726 Act: 34 Size: 199 KB 网页链接
产业链观察2022-09-02 21:42
药闻| $PolyPid(PYPD)$ 宣布D-PLEX₁₀₀预防腹部手术部位感染的3期SHIELD I试验的最高结果。研究没有达到降低手术部位感染和死亡率的主要终点。查看全文
7X24快讯2020-06-29 21:18
新朋股份：从金浦新兴产业基金获悉，其投资的境外公司PolyPid Ltd.,Israel（以色列）于6月26日在美国纳斯达克证券交易所正式挂牌上市。公司目前持有金浦新兴产业基金股权比例为63.42%，金浦新兴产业基金于2016年11月07日以500万美元投资PYPD。查看全文
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-053533 Act: 34 Size: 34 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-047069 Act: 34 Size: 166 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-044726 Act: 34 Size: 199 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040629 Act: 34 Size: 98 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-037474 Act: 34 Size: 29 KB 网页链接
$PolyPid(PYPD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-033795 Act: 34 Size: 46 KB 网页链接
$PolyPid(PYPD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-030807 Act: 34 Size: 73 KB 网页链接
$PolyPid(PYPD)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-24-020445 Act: 33 Size: 93 KB 网页链接
$PolyPid(PYPD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-24-020424 Act: 34 Size: 9 MB 网页链接
$PolyPid(PYPD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001622627-24-000016 Act: 34 Size: 94 KB 网页链接